UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 12.279

Sortiert nach

Reimbursement and pricing for innovative drugs in France: identifying criteria to inform decision-making

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.20-20

2021

Link zum Volltext

Verfügbarkeit prüfen

UK's NICE updated guideline recommends progesterone to prevent early miscarriage

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.37-37

2021

Link zum Volltext

Verfügbarkeit prüfen

ICER issues final evidence report for mavacamten for hypertrophic cardiomyopathy

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.34-34

2021

Link zum Volltext

Verfügbarkeit prüfen

Indacaterol/glycopyrronium/mometasone cost effective in Canada

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.10-10

2021

Link zum Volltext

Verfügbarkeit prüfen

Systemic sclerosis a significant patient and health resource economic burden

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.29-29

2021

Link zum Volltext

Verfügbarkeit prüfen

Extending mammography screening to age 80 cost effective in USA?

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.9-9

2021

Link zum Volltext

Verfügbarkeit prüfen

Semaglutide + metformin not cost effective vs empagliflozin + metformin for T2DM in Denmark

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.23-23

2021

Link zum Volltext

Verfügbarkeit prüfen

Willingness to pay for cancer treatments and outcomes: QOL valued similarly to 1-year survival

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.32-32

2021

Link zum Volltext

Verfügbarkeit prüfen

Olaparib cost effective for in BRCA-mutated advanced ovarian carcinoma in Spain

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.16-16

2021

Link zum Volltext

Verfügbarkeit prüfen

Most cost effective strategy for para-aortic lymph node detection in LACC patients in Thailand?

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.14-14

2021

Link zum Volltext

Verfügbarkeit prüfen

SAPIEN 3 TAVI cost effective vs surgical valve replacement for severe aortic stenosis in France

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.22-22

2021

Link zum Volltext

Verfügbarkeit prüfen

Costs outside Swedish health system influence long-term value of DAA treatment for HCV

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.5-5

2021

Link zum Volltext

Verfügbarkeit prüfen

Influenza vaccine cost effective in pregnant and older adults in Laos

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.11-11

2021

Link zum Volltext

Verfügbarkeit prüfen

Monoclonal antibodies in metastatic colorectal cancer: benefits at high cost

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.13-13

2021

Link zum Volltext

Verfügbarkeit prüfen

ICER posts draft scoping document for beta-thalassaemia treatment, betibeglogene autotemcel

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.35-35

2021

Link zum Volltext

Verfügbarkeit prüfen

Direct healthcare costs of patients with dyshidrotic eczema in the USA?

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.6-6

2021

Link zum Volltext

Verfügbarkeit prüfen

Costs increase with AF burden in older patients with implantable devices

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.4-4

2021

Link zum Volltext

Verfügbarkeit prüfen

Additional MRI more effective for initial staging in pancreatic cancer than standard imaging and less costly

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.3-3

2021

Link zum Volltext

Verfügbarkeit prüfen

Barriers to prescription drug access within US commercial insurance

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.33-33

2021

Link zum Volltext

Verfügbarkeit prüfen

Domiciliary ventilation cost effective after hospitalisation for COPD

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.7-7

2021

Link zum Volltext

Verfügbarkeit prüfen

Supplementary DECT imaging cost effective for diagnosing occult hip fractures in Singapore

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.26-26

2021

Link zum Volltext

Verfügbarkeit prüfen

Single-use clean intermittent catheters cost effective for managing neurogenic LUTD in Canada

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.25-25

2021

Link zum Volltext

Verfügbarkeit prüfen

A Fond Farewell from PharmacoEconomics & Outcomes News

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.1-1

2021

Link zum Volltext

Verfügbarkeit prüfen

Radiation therapy cost-effective option for low-risk localised prostate cancer in Australia

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.19-19

2021

Link zum Volltext

Verfügbarkeit prüfen

Pembrolizumab + EP not cost effective vs EP as first-line treatment for SCLC in the USA

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.17-17

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 12.279

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

SpracheUngarisch

Zeitschrift / SeriePharmacoeconomics & Outcomes News

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1)
Mit Volltextzugriff
(12.279)

Publikationsform

Artikel
(12.279)

Sprache

Englisch
(12.279)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Public Health
(12.279)
Health Economics
(12.277)
Medicine
(12.277)
Medicine & Public Health
(12.277)
Pharmacoeconomics And Health Outcomes
(12.277)
Quality Of Life Research
(12.277)
Clinical Study
(7.550)
News Item
(2.323)
Media Release
(1.281)
Non-Clinical Study
(334)
Analysis
(292)
Economic Aspects
(280)
Medical Care, Cost Of
(260)
Care And Treatment
(229)
Meeting Report
(219)
Health Aspects
(198)
Comment
(189)
Drug Therapy
(141)
Review
(123)
Guideline
(113)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Zeitschrift / Serie

Pharmacoeconomics
(1)

Menü

Weitere Dienste

Einstellungen

Reimbursement and pricing for innovative drugs in France: identifying criteria to inform decision-making

UK's NICE updated guideline recommends progesterone to prevent early miscarriage

ICER issues final evidence report for mavacamten for hypertrophic cardiomyopathy

Indacaterol/glycopyrronium/mometasone cost effective in Canada

Systemic sclerosis a significant patient and health resource economic burden

Extending mammography screening to age 80 cost effective in USA?

Semaglutide + metformin not cost effective vs empagliflozin + metformin for T2DM in Denmark

Willingness to pay for cancer treatments and outcomes: QOL valued similarly to 1-year survival

Olaparib cost effective for in BRCA-mutated advanced ovarian carcinoma in Spain

Most cost effective strategy for para-aortic lymph node detection in LACC patients in Thailand?

SAPIEN 3 TAVI cost effective vs surgical valve replacement for severe aortic stenosis in France

Costs outside Swedish health system influence long-term value of DAA treatment for HCV

Influenza vaccine cost effective in pregnant and older adults in Laos

Monoclonal antibodies in metastatic colorectal cancer: benefits at high cost

ICER posts draft scoping document for beta-thalassaemia treatment, betibeglogene autotemcel

Direct healthcare costs of patients with dyshidrotic eczema in the USA?

Costs increase with AF burden in older patients with implantable devices

Additional MRI more effective for initial staging in pancreatic cancer than standard imaging and less costly

Barriers to prescription drug access within US commercial insurance

Domiciliary ventilation cost effective after hospitalisation for COPD

Supplementary DECT imaging cost effective for diagnosing occult hip fractures in Singapore

Single-use clean intermittent catheters cost effective for managing neurogenic LUTD in Canada

A Fond Farewell from PharmacoEconomics & Outcomes News

Radiation therapy cost-effective option for low-risk localised prostate cancer in Australia

Pembrolizumab + EP not cost effective vs EP as first-line treatment for SCLC in the USA

Aktive Filter

Suchergebnisse filtern